KARLI NELSON: Open Payments
NPI 1871027847 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,171 in 63 payments from 11 companies in 2025. Trend: 2023 $1,469 · 2024 $1,281 · 2025 $1,171
Food & beverage: $1,171
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $235 |
| Lilly USA, LLC | 12 | $205 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $193 |
| Dexcom, Inc. | 7 | $142 |
| Tandem Diabetes Care, Inc. | 5 | $114 |
| Insulet Corporation | 4 | $76 |
| BETA BIONICS, INC. | 2 | $55 |
| Sequel Med Tech, LLC | 2 | $54 |
| Amgen Inc. | 3 | $42 |
| Abbott Laboratories | 2 | $38 |
Products named: JARDIANCE, MOUNJARO, Ozempic, Dexcom G6 Transmitter, t:slim X2 Insulin Pump with Control-IQ, Omnipod, Rybelsus, iLet Bionic Pancreas.
Industry payments across TX — which companies pay providers there.
